10035-41-3

Basic information

• Product Name: 2-Ethylbenzofuran-3-carbaldehyde
• Synonyms: 2-Ethyl-3-formylbenzofuran;2-Ethyl- 3-benzofurancarboxaldehyde;2-Ethylbenzofuran-3-carbaldehyde;2-ethyl-1-benzofuran-3-carbaldehyde(SALTDATA: FREE);3-Benzofurancarboxaldehyde, 2-ethyl-
• CAS NO: 10035-41-3
• Molecular Formula: C₁₁H₁₀O₂
• Molecular Weight: 174.2
• Product Categories: Heterocycles;Heterocyclic Compound
• Mol File: 10035-41-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 279.3°Cat760mmHg
• Flash Point: 125.5°C
• Appearance: /
• Density: 1.154g/cm³
• Vapor Pressure: 0.00404mmHg at 25°C
• Refractive Index: 1.615
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Ethylbenzofuran-3-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Ethylbenzofuran-3-carbaldehyde(10035-41-3)
• EPA Substance Registry System: 2-Ethylbenzofuran-3-carbaldehyde(10035-41-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 10035-41-3(Hazardous Substances Data)

Usage

General Description

2-Ethylbenzofuran-3-carbaldehyde, also known as CAS Number 128446-35-5, is a chemical compound categorized as a benzofuran. Its molecular formula is C12H12O2 and it has a molecular weight of 188.225 g/mol. This substance is often referred to by its CAS registry number rather than a common name. As of now, it is not widely discussed or researched in scientific literature, hence little is known regarding its properties or uses. It is recommended to handle it with appropriate protective clothing and in a well-ventilated area, like any other chemical compounds.

InChI:InChI=1/C11H10O2/c1-2-10-9(7-12)8-5-3-4-6-11(8)13-10/h3-7H,2H2,1H3

Upstream product

• 3131-63-3 2-ethylbenzofuran 
• 68-12-2 N,N-dimethyl-formamide 
• 90-02-8 salicylaldehyde 
• 271-89-6 1-benzofurane 
• 4885-02-3 Dichloromethyl methyl ether 
• 1646-26-0 1-(benzo[b]furan-2-yl)ethanone 

Downstream Products

• 92029-43-1 1-acetoxy-2-(3-ethyl-isoxazol-4-yl)-benzene 
• 88612-03-7 3-ethyl-4-(2-methoxy-phenyl)-isoxazole 
• 42901-97-3 2-ethyl-benzofuran-3-carbonitrile 
• 92287-69-9 2-ethyl-benzofuran-3-carbaldehyde oxime 
• 1133-47-7 2-(3-ethyl-isoxazol-4-yl)-phenol 
• 29936-00-3 6-(2-ethyl-benzofuran-3-yl)-4-morpholin-4-yl-1⁽⁵⁾,6-dihydro-[1,3,5]triazin-2-ylamine 
• 29936-01-4 N-[4-ethyl-5-(2-hydroxy-phenyl)-pyrimidin-2-yl]-morpholine-4-carboximidic acid amide 
• 80079-25-0 2-ethyl-3-methylbenzofuran 
• 102956-84-3 3t-(2-ethyl-benzofuran-3-yl)-1-(5-isopropyl-4-methoxy-2-methyl-phenyl)-propenone 

Relevant articles and documents

NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR ENHANCING ANTICANCER ACTIVITY

The present invention relates to a novel compound and a pharmaceutical composition for enhancing anticancer activity, which includes the same, and more particularly, to a pharmaceutical composition, which includes a compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, thereby enhancing anticancer activity of an anticancer agent or radiation, and inducing proliferation inhibition and death of cancer cells, resulting in effectively treating cancer: In Formula 1, n is an integer of 0 to 4; R1 is hydrogen, C1 to C10 alkyl or aryl(C1 to C4)alkyl; R3 is C1 to C6 alkyl, and when there are a plurality of the R3, the R3s are the same or different; L1 is a direct bond, or C1 to C6 alkylene; R2 is hydrogen, C1 to C10 alkyl or aryl(C1 to C4)alkyl, and R4 is hydrogen, C1 to C4 alkyl, C3 to C8 cycloalkyl or aryl(C1 to C4)alkyl, or R2 and R4 are connected to form a 4 to 7-membered ring; and the alkyl of R1 to R4, the arylalkyl of R1, R2 and R4, the cycloalkyl of R4, the alkylene of L1 are each independently unsubstituted or substituted with a substituent such as a C1 to C6 alkyl group, a halo group, an aryl group, a haloalkyl group, a nitro group, a cyano group, an alkylthio group or an arylalkylthio group, and when the compound is substituted with a plurality of substituents, the substituents are the same or different.